Baxter International Inc. (BAX)
NYSE: BAXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BAX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $12.39B
- Forward P/E
- 11.75
- EPS (TTM)
- -$1.88
- Dividend yield
- 0.83% ($0.20)
- Ex-dividend date
- Aug 28, 2026
- 52-week range
- 15.73 – 30.00
- Day range
- 23.83 – 24.60
- Volume / Avg
- 4.77M / 6.63M
- Beta
- —
- Shares outstanding
- 517.00M
- Next earnings
- Oct 29, 2026
52-week range
BAX stock today
Baxter International (BAX) closed at $23.97 on Oct 7, down 1.60% (-$0.39), versus the S&P 500's 0.22% decline. Shares are 20.1% below their 52-week high of $30.00, set on Jul 30, 2026 and 52.4% above the 52-week low of $15.73, in the middle of the past year's range. BAX is up 25.4% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 4.7%.
Baxter International has posted a net loss over the last twelve months (EPS of -$1.88), so its P/E ratio is not meaningful. Baxter International's next earnings report is expected on Oct 29, 2026. Baxter International pays an annual dividend of $0.20 per share, a 0.83% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Baxter International
Company profileBaxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Headquarters
- Deerfield, IL
- Employees
- 37,500
- Website
- baxter.com
Financial highlights
Full financialsIn fiscal 2025, Baxter International generated $11.24 billion in revenue, up 5.7% from fiscal 2024, its 3rd consecutive year of revenue growth. Baxter International reported a net loss of $957.0 million, compared with a loss of $649.0 million a year earlier. Gross margin was 30.1% (down from 37.5%) and operating margin -2.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $11.24B | $10.64B | $10.36B | $10.06B | $12.15B |
| Growth | +5.72% | +2.66% | +3.01% | -17.20% | +4.05% |
| Net income | $-957.00M | $-649.00M | $2.66B | $-2.43B | $1.28B |
| EPS (diluted) | $-1.87 | $-1.27 | $5.23 | $-4.83 | $2.53 |
Analyst forecast
ForecastConsensus (14 analysts)
hold
Avg. price target
$27.92+16.48%
- Strong buy 0
- Buy 2
- Hold 11
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 29, 2026
- EPS estimate
- $0.51
- Last reported (Q2 2026)
- Jul 30, 2026
- EPS actual vs est.
- $0.24 vs —
Dividends
Dividend history- Annual dividend
- $0.20
- Dividend yield
- 0.83%
- Last payment
- $0.01
- Ex-dividend date
- Aug 28, 2026
BAX news
All BAX news- Barclays Initiates Coverage of Baxter International at UnderweightNasdaqBAX, BCS
- Baxter to Host Third-Quarter 2026 Financial Results Conference Call for InvestorsBusiness Wire
- BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin PressureNasdaqBAX, BDX, ICUI
- WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?NasdaqWST, BDX, BAX, ATR
Baxter International peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PENPenumbra Inc. | 316.35 | -0.22% | $12.46B | vs BAX |
| SOLVSolventum Corporation | 85.88 | -1.33% | $14.62B | vs BAX |
| GKOSGlaukos Corporation | 172.18 | +6.55% | $10.16B | vs BAX |
| GMEDGlobus Medical Inc. Class A | 73.75 | -3.51% | $9.90B | vs BAX |
| PODDInsulet Corporation | 134.36 | -0.27% | $9.32B | vs BAX |
| MMEDMiniMed Group Inc. | 19.11 | -2.70% | $5.38B | vs BAX |
| STVNStevanato Group S.p.A. | 19.44 | -2.11% | $5.31B | vs BAX |
| TFXTeleflex Incorporated | 124.48 | -0.21% | $5.27B | vs BAX |
Indexes, lists and sector
Index membership
Appears in lists
Baxter International stock FAQ
What is Baxter International's stock price today?
BAX last traded at $23.97 as of Oct 7, 4:00 PM EDT, down 1.60% on the day. Prices are delayed at least 15 minutes.
Does Baxter International pay a dividend?
Yes. Baxter International pays $0.20 per share annually, a 0.83% yield. The most recent dividend of $0.01 had an ex-dividend date of Aug 28, 2026.
When is Baxter International's next earnings date?
Baxter International is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $0.51.
Is Baxter International in the S&P 500?
Yes. Baxter International (BAX) is a constituent of the S&P 500 index.
Has BAX ever split its stock?
Yes. The most recent BAX stock split was a 1841-for-1000 split on Jul 1, 2015, one of 5 splits on record.
What is the BAX 52-week high?
The 52-week high for BAX is $30.00 and the 52-week low is $15.73. The stock is currently 20.1% below its high.